Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Vaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice

dc.contributor.authorDobson, Bianca
dc.contributor.authorProcter, Dean J
dc.contributor.authorHollett, Natasha A
dc.contributor.authorFlesch, Inge E. A
dc.contributor.authorNewsome, Timothy P
dc.contributor.authorTscharke, David C
dc.date.accessioned2015-03-05T05:08:59Z
dc.date.available2015-03-05T05:08:59Z
dc.date.issued2014-04-05
dc.date.updated2015-12-08T03:32:49Z
dc.description.abstractVaccinia virus (VACV) gene F5L was recently identified as a determinant of plaque morphology that is truncated in Modified Vaccinia virus Ankara (MVA). Here we show that F5L also affects plaque morphology of the virulent VACV strain Western Reserve (WR) in some, but not all cell lines, and not via previously described mechanisms. Further, despite a reduction in plaque size for VACV WR lacking F5L there was no evidence of reduced virus replication or spread in vitro or in vivo. In vivo we examined two mouse models, each with more than one dose and measured signs of disease and virus burden. These data provide an initial characterization of VACV F5L in a virulent strain of VACV. Further they show the necessity of testing plaque phenotypes in more than one cell type and provide an example of a VACV gene required for normal plaque morphology but not replication and spread.
dc.description.sponsorshipThis work was funded by the Australian NHMRC: #418108 and APP1023141 (DCT) and Australian ARC: FT110100310 (DCT) and DP1096623 (TPN).en_AU
dc.identifier.issn0042-6822
dc.identifier.urihttp://hdl.handle.net/1885/12820
dc.publisherElsevier
dc.relationhttp://purl.org/au-research/grants/nhmrc/418108
dc.relationhttp://purl.org/au-research/grants/arc/FT110100310
dc.relationhttp://purl.org/au-research/grants/arc/DP1096623
dc.relationhttp://purl.org/au-research/grants/nhmrc/1023141
dc.rights© 2014 Elsevier Inc.
dc.rights.urihttps://www.elsevier.com/about/policies/open-access-licenses/elsevier-user-licenseen_AU
dc.sourceVirology
dc.subjectCell migration
dc.subjectCytopathic effect
dc.subjectModified vaccinia virus Ankara
dc.subjectPlaque morphology
dc.subjectVaccinia virus
dc.subjectAnimals
dc.subjectCell Line
dc.subjectDisease Models, Animal
dc.subjectFemale
dc.subjectGene Deletion
dc.subjectMice
dc.subjectMice, Inbred BALB C
dc.subjectVaccinia
dc.subjectViral Plaque Assay
dc.subjectViral Proteins
dc.subjectVirulence
dc.subjectVirus Replication
dc.titleVaccinia virus F5 is required for normal plaque morphology in multiple cell lines but not replication in culture or virulence in mice
dc.typeJournal article
dcterms.accessRightsOpen Accessen_AU
dcterms.accessRightsOpen Access via publisher websiteen_AU
dcterms.dateAccepted2014-03-19
local.bibliographicCitation.issue1
local.bibliographicCitation.lastpage156en_AU
local.bibliographicCitation.startpage145en_AU
local.contributor.affiliationTscharke, D., Research School of Biology, The Australian National Universityen_AU
local.contributor.authoruidu4334102en_AU
local.identifier.absfor060506 - Virology
local.identifier.absseo920109 - Infectious Diseases
local.identifier.ariespublicationu4008405xPUB39
local.identifier.citationvolume456-457en_AU
local.identifier.doi10.1016/j.virol.2014.03.020en_AU
local.identifier.essn1096-0341en_AU
local.identifier.scopusID2-s2.0-84897475911
local.identifier.thomsonID000337258600015
local.publisher.urlhttp://www.elsevier.com/en_AU
local.type.statusSubmitted Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Dobson et al Vaccinia virus F5 is required for normal plaque 2014.pdf
Size:
1.31 MB
Format:
Adobe Portable Document Format
Description:
Submitted version